Photobiomodulation therapy prevents dysgeusia chemotherapy induced in breast cancer women treated with doxorubicin plus cyclophosphamide: a triple-blinded, randomized, placebo-controlled clinical trial.
Cássia Emanuella Nóbrega MaltaAnna Clara Aragão Matos CarlosManuele Carine Maciel de AlencarEveline Fernandes Alves E SilvaVictor Bruno Caitano NogueiraAna Paula Negreiros Nunes AlvesFábio Figueiredo ChavesJosé Fernando Bastos de MouraPaulo Goberlânio de Barros SilvaPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Brazilian Clinical Trials Registry ( www.ensaiosclinicos.gov.br ) approval number RBR-9qnm34y, registered on 01/05/2021.
Keyphrases
- placebo controlled
- clinical trial
- double blind
- chemotherapy induced
- phase ii
- phase iii
- study protocol
- polycystic ovary syndrome
- breast cancer risk
- phase ii study
- open label
- drug delivery
- high dose
- low dose
- pregnancy outcomes
- newly diagnosed
- cell therapy
- metabolic syndrome
- insulin resistance
- bone marrow
- type diabetes
- skeletal muscle